OSTX — OS THERAPIES INCORPORATED
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -0.17 | — | -0.16 | -0.17 | 2 | — |
| Mar 2027 | -0.07 | — | -0.07 | -0.07 | 1 | — |
| Jun 2027 | -0.07 | — | -0.07 | -0.07 | 1 | — |
| Sep 2027 | 1.63 | 0.1× | 1.63 | 1.63 | 1 | — |
| Dec 2027 | -0.08 | — | -0.08 | -0.08 | 1 | — |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -0.73 | — | -0.71 | -0.75 | 2 | — |
| Dec 2027 | 0.59 | 1.5× | 1.41 | -0.22 | 2 | +1 |
| Dec 2028 | 1.10 | 0.8× | 2.29 | -0.10 | 2 | −1 |
| Dec 2029 | 1.45 | 0.6× | 2.73 | 0.16 | 2 | −1 |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 32 SEC-registered investment managers reported holding OSTX (OS THERAPIES INCORPORATED) in their latest 13F filings, with a combined reported value of $4.64M across 2.90M shares. That is +6.0% by share count (+130.68K shares) versus the previous quarter, while reported value moved -10.7%. Ownership is concentrated: the five largest holders account for 65.2% of reported value and the top ten for 86.4%.
Compared with the prior quarter, 10 opened new positions, 8 added to existing stakes, 4 trimmed, 9 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of OS THERAPIES INCORPORATED (OSTX) include VANGUARD CAPITAL MANAGEMENT LLC, CM Management, LLC, Vanguard Group, ranked by reported 13F value among the 54 institutional holders on this page.
OSTX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 32 | 2.90M | $4.64M | +8.6% |
| Q2 2026 | 30 | 3.08M | $5.85M | -3.6% |
| Q1 2026 | 30 | 2.90M | $4.09M | +33.0% |
| Q4 2025 | 26 | 1.81M | $2.53M | +15.9% |
| Q3 2025 | 26 | 1.65M | $3.23M | +8.2% |
| Q2 2025 | 13 | 594.81K | $1.12M | +17.7% |
| Q1 2025 | 7 | 390.09K | $600.53K | +192.1% |
| Q4 2024 | 7 | 175.52K | $751.23K | -0.7% |
Over the 8 quarters shown, institutional share counts increased 1551% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2025 (+192.1%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 777.65K | $1.24M | 0.00% | Hold | |
| 370.95K | $593.52K | 0.00% | Add | |
| 248.00K | $396.80K | 0.04% | Hold | |
| 245.86K | $393.37K | 0.00% | New | |
| 245.15K | $392.24K | 0.00% | Add | |
| 222.77K | $356.43K | 0.00% | Add | |
| 155.80K | $249.28K | 0.00% | Add | |
| 91.65K | $146.64K | 0.00% | Add | |
| 82.85K | $132.56K | 0.00% | Add | |
| 62.51K | $100.01K | 0.00% | Hold | |
| 52.00K | $83.20K | 0.00% | New | |
| 44.24K | $70.78K | 0.00% | New | |
| 44.24K | $70.78K | 0.00% | Reduce | |
| 40.22K | $64.00K | 0.00% | New | |
| 36.68K | $59.00K | 0.00% | Hold | |
| 27.90K | $44.64K | 0.00% | Hold | |
| 21.31K | $34.10K | 0.00% | Add | |
| 20.96K | $33.53K | 0.00% | Hold | |
| 20.00K | $32.00K | 0.00% | New | |
| 18.48K | $29.57K | 0.00% | Reduce | |
| 14.85K | $22.58K | 0.00% | New | |
| 13.30K | $22.08K | 0.00% | Reduce | |
| 13.00K | $20.80K | 0.00% | Hold | |
| 12.81K | $20.49K | 0.00% | Add | |
| 7.50K | $12.00K | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 777.65K | $1.48M | 0.00% | Add | |
| 400.00K | $760.00K | 0.48% | Hold | |
| 301.79K | $573.41K | 0.00% | New | |
| 301.79K | $573.41K | 0.00% | Add | |
| 248.00K | $471.20K | 0.05% | Add | |
| 242.48K | $460.71K | 0.00% | Add | |
| 174.13K | $330.85K | 0.00% | Add | |
| 100.64K | $191.22K | 0.00% | New | |
| 85.55K | $162.54K | 0.00% | Add | |
| 70.82K | $134.55K | 0.00% | Add | |
| 62.51K | $118.76K | 0.00% | Hold | |
| 45.00K | $85.50K | 0.00% | Add | |
| 36.68K | $70.00K | 0.00% | Hold | |
| 30.41K | $57.79K | 0.00% | Add | |
| 27.90K | $53.01K | 0.00% | Add | |
| 27.00K | $51.30K | 0.00% | Reduce | |
| 24.62K | $46.78K | 0.01% | New | |
| 20.96K | $39.82K | 0.00% | Hold | |
| 19.31K | $36.70K | 0.00% | Add | |
| 15.66K | $29.76K | 0.00% | New | |
| 14.50K | $27.26K | 0.00% | Add | |
| 13.53K | $25.71K | 0.00% | Reduce | |
| 13.00K | $24.70K | 0.00% | Add | |
| 8.81K | $16.75K | 0.00% | Reduce | |
| 7.50K | $14.25K | 0.00% | New |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 469.47K | $661.95K | 0.00% | New | |
| 448.74K | $632.72K | 0.00% | New | |
| 400.00K | $564.00K | 0.47% | Hold | |
| 348.68K | $491.64K | 0.00% | Add | |
| 280.05K | $394.86K | 0.00% | Add | |
| 245.44K | $346.06K | 0.04% | New | |
| 116.66K | $164.50K | 0.00% | New | |
| 91.20K | $128.59K | 0.00% | Add | |
| 66.05K | $93.14K | 0.00% | Reduce | |
| 64.77K | $91.33K | 0.00% | Add | |
| 62.51K | $88.14K | 0.00% | New | |
| 40.32K | $56.85K | 0.00% | Add | |
| 36.68K | $52.00K | 0.00% | Hold | |
| 32.00K | $45.12K | 0.01% | New | |
| 31.62K | $44.59K | 0.00% | New | |
| 26.38K | $37.20K | 0.00% | Reduce | |
| 25.00K | $35.25K | 0.00% | Hold | |
| 20.96K | $29.55K | 0.00% | New | |
| 15.20K | $21.43K | 0.00% | New | |
| 15.00K | $21.15K | 0.00% | Hold | |
| 13.82K | $19.48K | 0.00% | Hold | |
| 12.92K | $18.22K | 0.00% | Add | |
| 10.22K | $14.41K | 0.00% | Hold | |
| 10.11K | $14.26K | 0.00% | Hold | |
| 9.49K | $13.38K | 0.00% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 540.42K | $756.59K | 0.00% | Add | |
| 400.00K | $560.00K | 0.47% | Hold | |
| 246.04K | $344.45K | 0.00% | Add | |
| 109.95K | $153.93K | 0.00% | Reduce | |
| 87.54K | $122.55K | 0.00% | Add | |
| 71.31K | $99.83K | 0.00% | Add | |
| 61.42K | $86.00K | 0.00% | Add | |
| 58.50K | $81.90K | 0.00% | Add | |
| 36.68K | $51.00K | 0.00% | Hold | |
| 30.79K | $43.10K | 0.00% | Reduce | |
| 30.79K | $43.10K | 0.00% | Reduce | |
| 27.74K | $38.84K | 0.00% | New | |
| 25.00K | $35.00K | 0.00% | Hold | |
| 18.16K | $25.42K | 0.00% | Add | |
| 15.00K | $21.00K | 0.00% | Hold | |
| 13.82K | $19.34K | 0.00% | New | |
| 10.87K | $15.21K | 0.00% | Add | |
| 10.22K | $14.31K | 0.00% | Reduce | |
| 10.11K | $14.16K | 0.00% | New | |
| 1.30K | $1.82K | 0.00% | Hold | |
| 1.00K | $1.40K | 0.00% | Hold | |
| 480 | $1.00K | 0.00% | New | |
| 100 | $140 | 0.00% | Hold | |
| 88 | $123 | 0.00% | Reduce | |
| 25 | $35 | 0.00% | New |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 400.00K | $784.00K | 0.65% | Add | |
| 198.55K | $389.16K | 0.00% | New | |
| 188.26K | $369.00K | 0.00% | New | |
| 187.69K | $367.87K | 0.00% | New | |
| 93.57K | $183.41K | 0.00% | New | |
| 93.57K | $183.41K | 0.00% | New | |
| 86.25K | $169.04K | 0.00% | New | |
| 75.80K | $149.00K | 0.01% | Add | |
| 56.26K | $110.28K | 0.00% | New | |
| 50.30K | $98.59K | 0.00% | New | |
| 48.16K | $94.40K | 0.00% | Add | |
| 36.68K | $72.00K | 0.00% | Hold | |
| 25.00K | $49.00K | 0.00% | Hold | |
| 20.46K | $40.11K | 0.09% | New | |
| 20.44K | $40.06K | 0.00% | New | |
| 15.00K | $29.40K | 0.00% | Hold | |
| 14.96K | $29.32K | 0.00% | New | |
| 12.00K | $23.52K | 0.00% | New | |
| 10.24K | $20.07K | 0.00% | New | |
| 7.87K | $16.13K | 0.00% | New | |
| 4.17K | $8.17K | 0.00% | Add | |
| 1.30K | $2.55K | 0.00% | Hold | |
| 1.00K | $1.96K | 0.00% | Add | |
| 227 | $445 | 0.00% | Reduce | |
| 100 | $196 | 0.00% | Hold |
Q2 2025 — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 375.00K | $705.00K | 0.64% | Add | |
| 52.82K | $99.30K | 0.00% | New | |
| 36.68K | $69.00K | 0.00% | Hold | |
| 33.49K | $62.96K | 0.00% | New | |
| 30.28K | $56.93K | 0.00% | Reduce | |
| 25.00K | $47.00K | 0.00% | New | |
| 21.53K | $40.00K | 0.00% | New | |
| 15.00K | $28.20K | 0.00% | Hold | |
| 2.55K | $4.79K | 0.00% | New | |
| 1.30K | $2.44K | 0.00% | Add | |
| 740 | $1.39K | 0.00% | Add | |
| 322 | $605 | 0.00% | New | |
| 100 | $188 | 0.00% | Hold |
New Positions (Q3 2026)
- Citadel Advisors 245.86K sh · $393.37K
- Equitable Holdings, Inc. 52.00K sh · $83.20K
- Empowered Funds, LLC 44.24K sh · $70.78K
- HRT FINANCIAL LP 40.22K sh · $64.00K
- SANDERS MORRIS HARRIS LLC 20.00K sh · $32.00K
- StoneX Group Inc. 14.85K sh · $22.58K
- Tower Research Capital LLC (TRC) 2.65K sh · $4.24K
- Nuveen, LLC 1.79K sh · $2.89K
- Fidelity Management & Research (FMR) 242 sh · $387
- JPMorgan Chase & Co 162 sh · $261
Fully Exited (vs previous quarter)
- CM Management, LLC sold 400.00K sh · $760.00K
- GEODE CAPITAL MANAGEMENT, LLC sold 301.79K sh · $573.41K
- Marshall Wace sold 100.64K sh · $191.22K
- JANE STREET GROUP, LLC sold 27.00K sh · $51.30K
- AXQ CAPITAL, LP sold 24.62K sh · $46.78K
- Quadrature Capital Ltd sold 15.66K sh · $29.76K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP sold 13.53K sh · $25.71K
- Steward Partners Investment Advisory, LLC sold 5.68K sh · $10.79K
- BARCLAYS PLC sold 1.53K sh · $2.92K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 777.65K | 777.65K | 469.47K | — | — | — | — | — | — |
| Geode Capital Management | 370.95K | 301.79K | 280.05K | 246.04K | 187.69K | — | — | — | — |
| HOWARD FINANCIAL SERVICES, LTD. | 248.00K | 248.00K | 245.44K | — | — | — | — | — | — |
| Citadel Advisors | 245.86K | — | — | — | — | — | — | — | — |
| BlackRock Inc | 245.15K | 242.48K | 64.77K | 61.42K | 48.16K | 30.28K | 37.51K | 3.14K | — |
| VANGUARD FIDUCIARY TRUST CO | 222.77K | 174.13K | 116.66K | — | — | — | — | — | — |
| STATE STREET CORP | 155.80K | — | 91.20K | 58.50K | 50.30K | — | — | — | — |
| HighTower Advisors, LLC | 91.65K | 85.55K | 15.20K | — | — | — | — | — | — |
| Northern Trust Corp | 82.85K | 70.82K | 66.05K | 71.31K | 56.26K | — | — | — | — |
| Beacon Pointe Advisors, LLC | 62.51K | 62.51K | 62.51K | — | — | — | — | — | — |
| Equitable Holdings, Inc. | 52.00K | — | — | — | — | — | — | — | — |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 44.24K | 45.00K | 25.00K | 25.00K | 25.00K | 25.00K | — | — | — |
| Empowered Funds, LLC | 44.24K | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 40.22K | — | — | — | — | — | — | — | 17.58K |
| INGALLS & SNYDER LLC | 36.68K | 36.68K | 36.68K | 36.68K | 36.68K | 36.68K | 36.68K | — | — |
| STIFEL FINANCIAL CORP | 27.90K | 27.90K | 15.00K | 15.00K | 15.00K | 15.00K | 15.00K | — | — |
| Stratos Wealth Advisors, LLC | 21.31K | 19.31K | 13.82K | 13.82K | — | — | — | — | — |
| Vanguard Global Advisers, LLC | 20.96K | 20.96K | 20.96K | — | — | — | — | — | — |
| SANDERS MORRIS HARRIS LLC | 20.00K | — | 32.00K | — | 12.00K | — | — | — | — |
| Two Sigma Investments | 18.48K | 30.41K | 26.38K | 87.54K | 86.25K | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold OSTX?
As of 2026-Q3, 32 institutional funds reported holding OSTX (OS THERAPIES INCORPORATED) in SEC 13F filings, with a combined reported value of $4.64M.
How many shares of OSTX do institutions own?
13F filers reported 2.90M shares of OSTX, worth $4.64M in aggregate at the end of 2026-Q3.
Is institutional ownership of OSTX rising or falling?
Share counts moved +6.0% versus the prior quarter — accumulation.
Who are the top institutional holders of OSTX?
The largest 13F holders are VANGUARD CAPITAL MANAGEMENT LLC, CM Management, LLC, Vanguard Group, Geode Capital Management, GEODE CAPITAL MANAGEMENT, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of OS THERAPIES INCORPORATED?
The major shareholders of OS THERAPIES INCORPORATED (OSTX) by reported 13F value are VANGUARD CAPITAL MANAGEMENT LLC, CM Management, LLC, Vanguard Group, Geode Capital Management, GEODE CAPITAL MANAGEMENT, LLC, among 54 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.